OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19
D. Clark Files, Frank Tacke, Alexandra O’Sullivan, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010547-e1010547
Open Access | Times Cited: 25
D. Clark Files, Frank Tacke, Alexandra O’Sullivan, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010547-e1010547
Open Access | Times Cited: 25
Showing 25 citing articles:
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
Jane A. O’Halloran, Emily R. Ko, Kevin J. Anstrom, et al.
JAMA (2023) Vol. 330, Iss. 4, pp. 328-328
Open Access | Times Cited: 50
Jane A. O’Halloran, Emily R. Ko, Kevin J. Anstrom, et al.
JAMA (2023) Vol. 330, Iss. 4, pp. 328-328
Open Access | Times Cited: 50
Bat genomes illuminate adaptations to viral tolerance and disease resistance
Ariadna E. Morales, Yue Dong, Tom Brown, et al.
Nature (2025)
Open Access | Times Cited: 7
Ariadna E. Morales, Yue Dong, Tom Brown, et al.
Nature (2025)
Open Access | Times Cited: 7
Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway
Qi Tian, Yujia Guo, Feng Shi, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 57
Qi Tian, Yujia Guo, Feng Shi, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 57
Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table
Mitra Ranjbar, Ali Rahimi, Zeinab Baghernejadan, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109325-109325
Open Access | Times Cited: 45
Mitra Ranjbar, Ali Rahimi, Zeinab Baghernejadan, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109325-109325
Open Access | Times Cited: 45
Sulfoxides in medicine
Elżbieta Wojaczyńska, Jacek Wojaczyński
Current Opinion in Chemical Biology (2023) Vol. 76, pp. 102340-102340
Open Access | Times Cited: 33
Elżbieta Wojaczyńska, Jacek Wojaczyński
Current Opinion in Chemical Biology (2023) Vol. 76, pp. 102340-102340
Open Access | Times Cited: 33
CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in the murine model of the acute respiratory distress syndrome
А. С. Чернов, Maksim V. Rodionov, В. А. Казаков, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
А. С. Чернов, Maksim V. Rodionov, В. А. Казаков, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Naming the Barriers between Anti-CCR5 Therapy, Breast Cancer and Its Microenvironment
Elizabeth A. Brett, Dominik Duscher, Andrea Pagani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14159-14159
Open Access | Times Cited: 19
Elizabeth A. Brett, Dominik Duscher, Andrea Pagani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14159-14159
Open Access | Times Cited: 19
Reference-quality bat genomes illuminate adaptations to viral tolerance and disease resistance
Ariadna E. Morales, Yue Dong, Tom Brown, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 10
Ariadna E. Morales, Yue Dong, Tom Brown, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 10
Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection
Bryce M. Warner, Robert Vendramelli, Amrit S. Boese, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316952-e0316952
Open Access
Bryce M. Warner, Robert Vendramelli, Amrit S. Boese, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316952-e0316952
Open Access
Role of CCL2/CCR2 Axis in Pulmonary Fibrosis Induced by Respiratory Viruses
S Li, Mingming Pan, Hui Zhao, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
S Li, Mingming Pan, Hui Zhao, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Analysis of Stratifin Expression and Proteome Variation in a Rat Model of Acute Lung Injury
Ayaka Yoshida, Yoshiaki Hashimoto, Hirotoshi Akane, et al.
Journal of Proteome Research (2025)
Closed Access
Ayaka Yoshida, Yoshiaki Hashimoto, Hirotoshi Akane, et al.
Journal of Proteome Research (2025)
Closed Access
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury
Zhaoqing Li, Lu-Ning Qin, Xiaojian Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zhaoqing Li, Lu-Ning Qin, Xiaojian Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Do chemokine/chemokine receptor axes play paramount parts in trafficking and oriented locomotion of monocytes/macrophages toward the lungs of COVID-19 infected patients? A systematic review
Merat Mahmoodi, Fatemeh Mohammadi Henjeroei, Gholamhossein Hassanshahi, et al.
Cytokine (2024) Vol. 175, pp. 156497-156497
Closed Access | Times Cited: 3
Merat Mahmoodi, Fatemeh Mohammadi Henjeroei, Gholamhossein Hassanshahi, et al.
Cytokine (2024) Vol. 175, pp. 156497-156497
Closed Access | Times Cited: 3
Inflammatory Role of CCR1 in the Central Nervous System
Qi Tian, Ziang Yan, Yujia Guo, et al.
NeuroImmunoModulation (2024) Vol. 31, Iss. 1, pp. 173-182
Open Access | Times Cited: 3
Qi Tian, Ziang Yan, Yujia Guo, et al.
NeuroImmunoModulation (2024) Vol. 31, Iss. 1, pp. 173-182
Open Access | Times Cited: 3
Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells
Upasna Madan, Bhawna Verma, Amit Awasthi
European Journal of Immunology (2024) Vol. 54, Iss. 7
Closed Access | Times Cited: 2
Upasna Madan, Bhawna Verma, Amit Awasthi
European Journal of Immunology (2024) Vol. 54, Iss. 7
Closed Access | Times Cited: 2
Novel artesunate and isatin hybrid CT3-1 suppresses collagen-induced arthritis through abrogating dendritic cell chemotaxis-induced by CCR5
Juan He, Xian Lin, Xu Gao, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112264-112264
Closed Access | Times Cited: 2
Juan He, Xian Lin, Xu Gao, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112264-112264
Closed Access | Times Cited: 2
Virus‐Induced Host Chemokine CCL2 in COVID‐19 Pathogenesis: Potential Prognostic Marker and Target of Anti‐Inflammatory Strategy
A Ansari, Fareed Ahmad, Majid Alam, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 5
Open Access | Times Cited: 2
A Ansari, Fareed Ahmad, Majid Alam, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 5
Open Access | Times Cited: 2
Innate immunity champions: The diverse functions of macrophages
Francesca Biscu, Anissa Zouzaf, Donatella Cicia, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 12
Closed Access | Times Cited: 1
Francesca Biscu, Anissa Zouzaf, Donatella Cicia, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 12
Closed Access | Times Cited: 1
Antiviral Agents: Structural Basis of Action and Rational Design
Luis Menéndez‐Arias, Federico Gago
Sub-cellular biochemistry/Subcellular biochemistry (2024), pp. 745-784
Closed Access | Times Cited: 1
Luis Menéndez‐Arias, Federico Gago
Sub-cellular biochemistry/Subcellular biochemistry (2024), pp. 745-784
Closed Access | Times Cited: 1
Integrative single‐cell transcriptome analysis provides new insights into post‐COVID‐19 pulmonary fibrosis and potential therapeutic targets
Yumin Kim, Yeongmin Kim, Hyobin Julianne Lim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access | Times Cited: 2
Yumin Kim, Yeongmin Kim, Hyobin Julianne Lim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Open Access | Times Cited: 2
Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises
Austė Kanapeckaitė, Asta Mažeikienė, Liesbet Geris, et al.
Biophysical Chemistry (2022) Vol. 290, pp. 106891-106891
Open Access | Times Cited: 3
Austė Kanapeckaitė, Asta Mažeikienė, Liesbet Geris, et al.
Biophysical Chemistry (2022) Vol. 290, pp. 106891-106891
Open Access | Times Cited: 3
Cysteine-cysteine Chemokine Receptor Type 5 Plays a Critical Role in Exercise Performance by Regulating Mitochondrial Content in Skeletal Muscle
Chien‐Wei Chen, Luen-Kui Chen, Yi‐Ting Chung, et al.
Inflammation (2023) Vol. 46, Iss. 6, pp. 2089-2101
Closed Access | Times Cited: 1
Chien‐Wei Chen, Luen-Kui Chen, Yi‐Ting Chung, et al.
Inflammation (2023) Vol. 46, Iss. 6, pp. 2089-2101
Closed Access | Times Cited: 1
Therapeutic Considerations in HIV-Associated Neurocognitive Disorders (HAND)
Adam Adelsberg, Dennis L. Kolson
NeuroImmune Pharmacology and Therapeutics (2024), pp. 719-742
Closed Access
Adam Adelsberg, Dennis L. Kolson
NeuroImmune Pharmacology and Therapeutics (2024), pp. 719-742
Closed Access
Integrative single-cell transcriptome analysis reveals new insights into post-COVID-19 pulmonary fibrosis and potential therapeutic targets
Yumin Kim, Hyobin Julianne Lim, Dae‐Kyum Kim, et al.
Research Square (Research Square) (2023)
Open Access
Yumin Kim, Hyobin Julianne Lim, Dae‐Kyum Kim, et al.
Research Square (Research Square) (2023)
Open Access
CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model of the SARS-CoV-2-related acute respiratory distress syndrome
А. С. Чернов, Maksim V. Rodionov, В. А. Казаков, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
А. С. Чернов, Maksim V. Rodionov, В. А. Казаков, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
